HER2/neu Expression in Relation to Clinicopathologic Features of Breast Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2/neu Expression in Relation to Clinicopathologic Features of Breast Cancer Patients

Published:2006-11-01 Issue:1 Volume:1089 Page:159-167
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

TRAINA A.,AGOSTARA B.,MARASA L.,CALABRO M.,ZARCONE M.,CARRUBA G.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1386.029/fullpdf

Reference21 articles.

1. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.

2. The biology of erbB-2/nue/HER-2 and its role in cancer

3. The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase Activity

4. The neu oncogene encodes an epidermal growth factor receptor-related protein

5. Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool;PLOS ONE;2023-07-17

2. MicroRNA-26a-5p as a potential predictive factor for determining the effectiveness of trastuzumab therapy in HER-2 positive breast cancer patients;BioMedicine;2021-05-27

3. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study;Diagnostic Pathology;2019-05-04

4. Double-Equivocal HER2 Invasive Breast Carcinomas: Institutional Experience and Review of Literature;Archives of Pathology & Laboratory Medicine;2018-03-29

5. A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens;Cancer Immunology, Immunotherapy;2014-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3